BME Homepage |
Background
|
Background Information of Current Systems A controlled release system is a device for controlled the release time of a chemical, and/or the release rate. In the field of drug delivery, the amount delivered over a certain time frame is critical depending on the therapeutic purpose and the patient. If drug concentrations are below this specific range, then there is no therapeutic benefit for the patient. However, if drug concentrations are too much, then the drug can have toxic effects and can possibly pose substantial danger or death to the patient.
A common example of a sustained drug release system is one that utilizes polymers to constantly diffuse drug from within through gradual degradation. The systems can exist as oral tablets, polymer implants or microspheres. Commercially available products include Gliadel and Lupron Depot [2,3]. Another example of sustained drug release systems include transdermal delivery through the skin that can be used through such lipophillic drug molecules such as estradiol and nitroglycerin. The limitation to drug application through the skin however is the establishment of a stable concentration of drug in the blood stream. Figure:. A comparison of sustained drug release versus pulsatile release, in which r is the rate of drug release and t is time. (Picture Rights belong to [1]) Pumps and catheters are another form of release that rivals pulsatile drug delivery. Pumps can also be programmed to apply pulsatile drug delivery through a catheter within the patient. The problem with pumps and catheter delivery systems are the inconvenience, large size, expense, and discomfort or infections experienced at the catheter site.
|